Intensity Therapeutics surges 395% on phase 1/2 data for solid tumors asset
Intensity Therapeutics (INTS), with a ~$13M market cap, closed up nearly 395% Thursday after publishing phase ...
Tag: Therapeutics
Zevra Therapeutics Stock Sees Healthy RS Rating Jump To 73
In a welcome move, Zevra Therapeutics (ZVRA) saw its Relative Strength Rating rise from 62 to ...
Hoth Therapeutics, Inc. (HOTH) Files EMA Application for Global Expansion of HT-001 Skin Therapy
In this article, we will be taking a look at the 15 Best Biotech Penny Stocks ...